Authorized purpose: Aid dentists in detecting and segmenting caries on bitewing and periapical radiographs for patients aged 4-11 with primary or permanent teeth; the output is additional information and does not replace a complete dental review or clinical judgment.
Clinical role
Concurrent-read CADe detection and segmentation adjunct that presents editable polygon annotations for suspected caries to clinician reviewers.
Keep in mind: Not a replacement for a dentist's complete review or clinical judgment and not for standalone patient-management decisions. The labeled scope is limited to bitewing and periapical radiographs and patients aged 4-11 with primary or permanent teeth; FDA testing covered 1,190 standalone images and a 636-image reader study, so performance outside the tested image and sensor populations requires confirmation.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Aid dentists in detecting and segmenting caries on bitewing and periapical radiographs for patients aged 4-11 with primary or permanent teeth; the output is additional information and does not replace a complete dental review or clinical judgment.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Dental/Maxillofacial (carious tooth surfaces) Input: Bitewing and periapical radiographs from patients aged 4-11 with primary or permanent teeth, including primary or mixed dentition, who are indicated for dental radiographs.
Who uses it?Intended users: Dentists and dental clinicians; the FDA packet emphasizes the dentist's complete review and clinical judgment.
What does the software produce?Output: Polygon annotations for suspected caries at the tooth surface or tooth level; annotations can be adjusted, hidden, deleted, and viewed with or without a color fill.
What is its most important limitation?Key limitation: Not a replacement for a dentist's complete review or clinical judgment and not for standalone patient-management decisions. The labeled scope is limited to bitewing and periapical radiographs and patients aged 4-11 with primary or permanent teeth; FDA testing covered 1,190 standalone images and a 636-image reader study, so performance outside the tested image and sensor populations requires confirmation.
Clinical takeaway. Clinical role: Aid dentists in detecting and segmenting caries on bitewing and periapical radiographs for patients aged 4-11 with primary or permanent teeth; the output is additional information and does not replace a complete dental review or clinical judgment.
Evidence takeaway. Evidence from the reviewed source record: FDA K233738 reports a fully crossed MRMC reader-improvement study with 20 US licensed dentists, 636 images, and a consensus reference standard from three general dentists. Average wAFROC improvement was 7.5% with reported 95% CI (0.062, 0.088), and average tooth-level sensitivity increased 11.8% with a slight specificity decrease. Standalone testing used 1,190 bitewing and periapical images with a three-dentist consensus standard: tooth-level sensitivity 83.9% (95% CI 81.6%-86.0%), specificity 97.5% (95% CI 97.1%-97.9%), and mean Dice 79.0% (95% CI 78.4%-79.7%).
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Aid dentists in detecting and segmenting caries on bitewing and periapical radiographs for patients aged 4-11 with primary or permanent teeth; the output is additional information and does not replace a complete dental review or clinical judgment.
Bitewing and periapical radiographs from patients aged 4-11 with primary or permanent teeth, including primary or mixed dentition, who are indicated for dental radiographs.
Polygon annotations for suspected caries at the tooth surface or tooth level; annotations can be adjusted, hidden, deleted, and viewed with or without a color fill.
Dental clinic or dental-office workflow; the FDA device description says images are pulled from a clinic or dental office but does not establish a broader facility setting.
Not a replacement for a dentist's complete review or clinical judgment and not for standalone patient-management decisions. The labeled scope is limited to bitewing and periapical radiographs and patients aged 4-11 with primary or permanent teeth; FDA testing covered 1,190 standalone images and a 636-image reader study, so performance outside the tested image and sensor populations requires confirmation.
FDA K233738 reports a fully crossed MRMC reader-improvement study with 20 US licensed dentists, 636 images, and a consensus reference standard from three general dentists. Average wAFROC improvement was 7.5% with reported 95% CI (0.062, 0.088), and average tooth-level sensitivity increased 11.8% with a slight specificity decrease. Standalone testing used 1,190 bitewing and periapical images with a three-dentist consensus standard: tooth-level sensitivity 83.9% (95% CI 81.6%-86.0%), specificity 97.5% (95% CI 97.1%-97.9%), and mean Dice 79.0% (95% CI 78.4%-79.7%).
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA K233738 reports a fully crossed MRMC reader-improvement study with 20 US licensed dentists, 636 images, and a consensus reference standard from three general dentists. Average wAFROC improvement was 7.5% with reported 95% CI (0.062, 0.088), and average tooth-level sensitivity increased 11.8% with a slight specificity decrease. Standalone testing used 1,190 bitewing and periapical images with a three-dentist consensus standard: tooth-level sensitivity 83.9% (95% CI 81.6%-86.0%), specificity 97.5% (95% CI 97.1%-97.9%), and mean Dice 79.0% (95% CI 78.4%-79.7%).
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Overjet Caries Assist-Pediatric regulatory performance study summary
DesignStand-alone performance and reader study (ACR AI Central category)
PopulationPediatric
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K233738
Samplen=1190
IndependenceIndependence not established
K233738
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K233738. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Bitewing and periapical radiographs from patients aged 4-11 with primary or permanent teeth, including primary or mixed dentition, who are indicated for dental radiographs.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Software-only three-layer Network, Presentation, and Decision architecture; images are pulled from a clinic or dental office and predictions are pushed to a dashboard. The FDA packet does not establish DICOM, PACS, RIS, EHR, or a specific deployment model.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The exact FDA decision document was reviewed on 2026-11-14 and does not state where the subject device's software runs or how it is hosted. Confirm the deployment model, hosting, data flow, and current commercial configuration with the vendor.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 ·
Returned objects
Source context, not route validation: Polygon annotations for suspected caries at the tooth surface or tooth level; annotations can be adjusted, hidden, deleted, and viewed with or without a color fill.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Polygon annotations for suspected caries at the tooth surface or tooth level; annotations can be adjusted, hidden, deleted, and viewed with or without a color fill.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Software-only three-layer Network, Presentation, and Decision architecture; images are pulled from a clinic or dental office and predictions are pushed to a dashboard. The FDA packet does not establish DICOM, PACS, RIS, EHR, or a specific deployment model.
Overjet's trust center states a completed independent HITRUST audit and certification, HIPAA business associate compliance, GDPR and CCPA alignment, third-party penetration tests, need-to-know data access and employee security training. Vendor-wide.
Vendor-wide
Checked 2026-10-25
Vendor statement, not an attestation; exact-release scope is not established.
ACR AI Central provides an exact-submission model card for Overjet Caries Assist-Pediatric; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
24Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K233738 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not publicly available - checked 2026-11-14 - Exact FDA submission
The exact FDA decision document was reviewed on 2026-11-14 and does not state where the subject device's software runs or how it is hosted. Confirm the deployment model, hosting, data flow, and current commercial configuration with the vendor.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.
Authorized purpose: Acts as a CADe second reader to detect and segment caries on periapical radiographs of permanent teeth in patients aged 12 years and older; clinicians review the contours and percentage analysis in context.
Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.
Authorized purpose: Concurrent-read CADe to aid professionally trained and licensed dentists in detecting and segmenting caries on bitewing and periapical radiographs; the output is additional information and does not replace dentist review or clinical judgment.
Modality
X-ray/Radiography
Anatomy
Permanent dentition and tooth surfaces in dental/maxillofacial anatomy
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.